2021 annual financial data

Compass Therapeutics, Inc. 2021 Operating cash flow

Compass Therapeutics, Inc. 2021 operating cash flow with verified reported valu…

Direct answer

Operating cash flow was -19,666,000 USD.

Operating income was -81,882,000 USD and net income was -82,181,000 USD.
Operating cash flow was -19,666,000 USD.

Get free Compass Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-81,882,000 USD
Net income
-82,181,000 USD
Operating cash flow
-19,666,000 USD